Cargando…
Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19
Autores principales: | Tendilla-Beltrán, Hiram, Flores, Gonzalo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141345/ https://www.ncbi.nlm.nih.gov/pubmed/34045093 http://dx.doi.org/10.1016/j.genhosppsych.2021.05.005 |
Ejemplares similares
-
Atypical antipsychotics, more than just an antipsychotic
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2020) -
Antipsychotics modified COVID-19 prevalence in hospitalized patients diagnosed with mental illnesses
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2023) -
Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia
por: Caruso, Giuseppe, et al.
Publicado: (2020) -
Efficacy and Tolerability of Second-Generation Antipsychotics in Children and Adolescents With Schizophrenia
por: Kumra, Sanjiv, et al.
Publicado: (2008) -
Adherence and Continuation of Treatment with First- and Second-generation Antipsychotics in Schizophrenia
por: Warikoo, Nisha, et al.
Publicado: (2014)